Celgene Corp (NASDAQ:CELG)

During the Trading Day
108.65 +1.11 / +1.03%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
108.65 0.00 / 0.00%
 
Volume: 81.2K
bluebird bio Plans to Sing in June
8:41pm / MotleyFool.com
Celgene Posts Higher Q1 Earnings, But Sales Miss Expectations
Apr 30 / Benzinga
3 Stocks Raising The Drugs Industry Higher
1:17pm / TheStreet.com
Morning Market Losers
Apr 30 / Benzinga
Stock Market News for May 06, 2015 - Market News
10:48am / Zacks.com
Cramer -- Yelp Suffers as Business Slows; Celgene Earnings Disappoint
Apr 30 / TheStreet.com
The Zacks Analyst Blog Highlights: Celgene, Laboratory Corp. of America Holdings, Que...
10:15am / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Celladon, Biogen, Celgene and Gilead - Pres...
Apr 30 / Zacks.com
Will Agios (AGIO) Disappoint this Earnings Season? - Analyst Blog
May 05 / Zacks.com
Celgene Corp.'s Earnings Hint at Big Things to Come
Apr 30 / MotleyFool.com
Beyond Pharma: 3 Healthcare Choices - Analyst Blog
May 05 / Zacks.com
Celgene (CELG) Beats on Q1 Earnings, Shares Down - Tale of the Tape
Apr 30 / Zacks.com
Biotechs' fees soar for drug development partnerships
May 05 / FT.com
Benzinga's Top #PreMarket Losers
Apr 30 / Benzinga
Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?
May 05 / MotleyFool.com
Earnings Scheduled For April 30, 2015
Apr 30 / Benzinga
Here's What's Driving Biotech
May 04 / TheStreet.com
Biotech Stock Roundup: Weakness in Biotech Sector on Amgen & Celladon News - Analyst ...
Apr 29 / Zacks.com
Biotech's Blue Chip Stocks
May 04 / MotleyFool.com
Will Celgene (CELG) Beat Q1 Earnings on Strong Sales? - Analyst Blog
Apr 28 / Zacks.com
CEO Gives America All A's; the Forbidden Apple: Jim Cramer's Best Blogs
May 02 / TheStreet.com
Celgene to Buy Quanticel, Boost Pipeline Development - Analyst Blog
Apr 28 / Zacks.com
3 Stocks Reiterated As A Buy: CELG, GM, ORCL
May 01 / TheStreet.com
Stock Market News for April 28, 2015 - Market News
Apr 28 / Zacks.com
3 Stocks Reiterated As A Buy: CELG, ALXN, GM
May 01 / TheStreet.com
Biotech Bubble Bursting? 3 Stocks I Want to Buy
Apr 27 / MotleyFool.com
Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover
May 01 / TheStreet.com
AstraZeneca Falls on Q1 Earnings Decline, Reiterates View - Analyst Blog
Apr 27 / Zacks.com
Stock Market News for May 01, 2015 - Market News
May 01 / Zacks.com
3 Mega-Cap Stocks That Shouldn't Pay a Dividend
Apr 26 / MotleyFool.com
Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Rel...
May 01 / Benzinga
AstraZeneca Inks Multiple Deals, Immuno-Oncology in Focus - Analyst Blog
Apr 24 / Zacks.com
Celgene Corporation Hits a Triple, Yet Investors Boo
Apr 30 / MotleyFool.com
AstraZeneca forced to defend cancer drug deal with Celgene
Apr 24 / FT.com
Celgene (CELG) Earnings Report: Q1 2015 Conference Call Transcript
Apr 30 / TheStreet.com
Biotech: Making sense of the science
Apr 13 / FT.com
Celgene Beats on Q1 Earnings, Misses Revenues, Keeps View - Analyst Blog
Apr 30 / Zacks.com
Big pharma turns to small biotechs for edge in cancer treatment
Apr 07 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account